F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Diabetic cardiomyopathy

Page 1 of 1 ( 38 items )
<<
1
>>

1	Effects of 5-methoxytryptophan on cardiac structure and functions in a rat model of diabetic cardiomyopathy 8/26/2026 5:34:15 AM \| Browse: 23 \| Download: 60
2	Is the cellular attribution of liraglutide action in diabetic cardiomyopathy conclusive? 7/9/2026 6:58:25 AM \| Browse: 31 \| Download: 44
3	Regulation of ferroptosis and mitochondrial homeostasis disruption in diabetic cardiomyopathy: Therapeutic potential of traditional Chinese medicine 7/9/2026 6:58:20 AM \| Browse: 12 \| Download: 31
4	Farrerol and the miR-29b-3p/sirtuin 1 pathway: A mechanistic breakthrough in protecting the diabetic heart 2/6/2026 8:43:33 AM \| Browse: 107 \| Download: 336
5	Microtubule affinity-regulating kinase 4 exacerbates diabetic cardiomyopathy by inhibiting UNC-51-like kinase 1-mediated mitochondrial autophagy 1/14/2026 8:09:14 AM \| Browse: 177 \| Download: 342
6	Right ventricular dysfunction in type 1 diabetic cardiomyopathy: An overlooked component? 1/14/2026 8:09:13 AM \| Browse: 122 \| Download: 395
7	Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathway 12/15/2025 9:46:09 AM \| Browse: 141 \| Download: 663
8	Beyond the left ventricle: Right ventricular dysfunction as a critical determinant in type 1 diabetes-related cardiomyopathy 12/15/2025 9:46:06 AM \| Browse: 149 \| Download: 371
9	Right ventricular dysfunctions in type 1 diabetic mice: A longitudinal study 10/15/2025 9:03:23 AM \| Browse: 136 \| Download: 603
10	Epicardial adipose tissue in diabetic myocardial disorder: Role of echocardiography 10/15/2025 9:03:21 AM \| Browse: 174 \| Download: 477
11	Farrerol ameliorates diabetic cardiomyopathy by inhibiting ferroptosis via miR-29b-3p/SIRT1 signaling pathway in endothelial cells 9/11/2025 9:41:58 AM \| Browse: 337 \| Download: 797
12	Ferroptosis: A novel therapeutic target for diabetic cardiomyopathy 6/13/2025 11:47:55 AM \| Browse: 273 \| Download: 697
13	Double-edged sword of L-arginine in diabetes: Exploring anti-inflammatory and antioxidant strategies 2/28/2025 10:47:24 AM \| Browse: 392 \| Download: 694
14	Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure 1/21/2025 6:56:34 AM \| Browse: 270 \| Download: 723
15	Sodium-dependent glucose transporter 2 inhibitors: Transforming diabetic cardiomyopathy management 11/26/2024 9:16:41 AM \| Browse: 130 \| Download: 660
16	Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies 11/18/2024 3:30:39 AM \| Browse: 245 \| Download: 739
17	Identification of immune feature genes and intercellular profiles in diabetic cardiomyopathy 9/26/2024 8:51:02 AM \| Browse: 269 \| Download: 966
18	Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy 9/26/2024 8:51:01 AM \| Browse: 327 \| Download: 994
19	Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy? 8/27/2024 3:11:19 PM \| Browse: 313 \| Download: 958
20	Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure 8/26/2024 12:59:17 PM \| Browse: 111 \| Download: 690
21	Diabetic cardiomyopathy: Importance of direct evidence to support the roles of NOD-like receptor protein 3 inflammasome and pyroptosis 7/26/2024 6:56:09 AM \| Browse: 276 \| Download: 772
22	Diabetic cardiomyopathy: Emerging therapeutic options 7/26/2024 6:56:09 AM \| Browse: 341 \| Download: 709
23	Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy 6/11/2024 2:35:35 PM \| Browse: 210 \| Download: 888
24	Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome 4/12/2024 1:04:39 AM \| Browse: 199 \| Download: 1558
25	Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1a and inhibiting the RhoA/ROCK pathway 12/14/2023 9:36:12 AM \| Browse: 353 \| Download: 1772
26	Atorvastatin ameliorated myocardial fibrosis in db/db mice by inhibiting oxidative stress and modulating macrophage polarization 12/14/2023 9:36:12 AM \| Browse: 479 \| Download: 1487
27	Potential therapeutic targets for the prevention of diabetic nephropathy: Glycyrrhetinic acid 12/14/2023 9:36:11 AM \| Browse: 412 \| Download: 1202
28	Molecular targets and mechanisms of Jiawei Jiaotai Pill on diabetic cardiomyopathy based on network pharmacology 11/14/2023 6:13:55 AM \| Browse: 481 \| Download: 1701
29	Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy 5/13/2022 10:36:57 AM \| Browse: 782 \| Download: 1919
30	Roles of transient receptor potential channel 6 in glucose-induced cardiomyocyte injury 4/14/2022 11:27:05 AM \| Browse: 781 \| Download: 2356
31	Role of novel biomarkers in diabetic cardiomyopathy 6/4/2021 1:47:10 PM \| Browse: 856 \| Download: 2083
32	Diabetic heart disease: A clinical update 4/9/2021 5:27:04 AM \| Browse: 928 \| Download: 2157
33	Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date 10/15/2019 3:36:45 AM \| Browse: 1121 \| Download: 1774
34	Trace elements in diabetic cardiomyopathy: An electrophysiological overview 9/1/2014 3:13:00 PM \| Browse: 1472 \| Download: 1488
35	Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management 9/1/2014 3:02:00 PM \| Browse: 1312 \| Download: 1350
36	Cardiac autonomic neuropathy in patients with diabetes mellitus 9/1/2014 12:00:00 PM \| Browse: 1831 \| Download: 1820
37	Is diabetic cardiomyopathy a specific entity? 8/27/2014 5:24:00 PM \| Browse: 1126 \| Download: 1256
38	Mechanisms underlying the impaired contractility of diabetic cardiomyopathy 8/22/2014 2:47:00 PM \| Browse: 1264 \| Download: 1418

Page 1 of 1 ( 38 items )
<<
1
>>

1	Effects of 5-methoxytryptophan on cardiac structure and functions in a rat model of diabetic cardiomyopathy 8/26/2026 5:34:15 AM \| Browse: 23 \| Download: 60
2	Is the cellular attribution of liraglutide action in diabetic cardiomyopathy conclusive? 7/9/2026 6:58:25 AM \| Browse: 31 \| Download: 44
3	Regulation of ferroptosis and mitochondrial homeostasis disruption in diabetic cardiomyopathy: Therapeutic potential of traditional Chinese medicine 7/9/2026 6:58:20 AM \| Browse: 12 \| Download: 31
4	Farrerol and the miR-29b-3p/sirtuin 1 pathway: A mechanistic breakthrough in protecting the diabetic heart 2/6/2026 8:43:33 AM \| Browse: 107 \| Download: 336
5	Microtubule affinity-regulating kinase 4 exacerbates diabetic cardiomyopathy by inhibiting UNC-51-like kinase 1-mediated mitochondrial autophagy 1/14/2026 8:09:14 AM \| Browse: 177 \| Download: 342
6	Right ventricular dysfunction in type 1 diabetic cardiomyopathy: An overlooked component? 1/14/2026 8:09:13 AM \| Browse: 122 \| Download: 395
7	Liraglutide alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic rats by enhancing mitophagy mediated by the AMPK-Parkin signaling pathway 12/15/2025 9:46:09 AM \| Browse: 141 \| Download: 663
8	Beyond the left ventricle: Right ventricular dysfunction as a critical determinant in type 1 diabetes-related cardiomyopathy 12/15/2025 9:46:06 AM \| Browse: 149 \| Download: 371
9	Right ventricular dysfunctions in type 1 diabetic mice: A longitudinal study 10/15/2025 9:03:23 AM \| Browse: 136 \| Download: 603
10	Epicardial adipose tissue in diabetic myocardial disorder: Role of echocardiography 10/15/2025 9:03:21 AM \| Browse: 174 \| Download: 477
11	Farrerol ameliorates diabetic cardiomyopathy by inhibiting ferroptosis via miR-29b-3p/SIRT1 signaling pathway in endothelial cells 9/11/2025 9:41:58 AM \| Browse: 337 \| Download: 797
12	Ferroptosis: A novel therapeutic target for diabetic cardiomyopathy 6/13/2025 11:47:55 AM \| Browse: 273 \| Download: 697
13	Double-edged sword of L-arginine in diabetes: Exploring anti-inflammatory and antioxidant strategies 2/28/2025 10:47:24 AM \| Browse: 392 \| Download: 694
14	Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure 1/21/2025 6:56:34 AM \| Browse: 270 \| Download: 723
15	Sodium-dependent glucose transporter 2 inhibitors: Transforming diabetic cardiomyopathy management 11/26/2024 9:16:41 AM \| Browse: 130 \| Download: 660
16	Teneligliptin mitigates diabetic cardiomyopathy through inflammasome inhibition: Insights from experimental studies 11/18/2024 3:30:39 AM \| Browse: 245 \| Download: 739
17	Identification of immune feature genes and intercellular profiles in diabetic cardiomyopathy 9/26/2024 8:51:02 AM \| Browse: 269 \| Download: 966
18	Potential mechanism of teneligliptin in the treatment of diabetic cardiomyopathy 9/26/2024 8:51:01 AM \| Browse: 327 \| Download: 994
19	Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy? 8/27/2024 3:11:19 PM \| Browse: 313 \| Download: 958
20	Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure 8/26/2024 12:59:17 PM \| Browse: 111 \| Download: 690
21	Diabetic cardiomyopathy: Importance of direct evidence to support the roles of NOD-like receptor protein 3 inflammasome and pyroptosis 7/26/2024 6:56:09 AM \| Browse: 276 \| Download: 772
22	Diabetic cardiomyopathy: Emerging therapeutic options 7/26/2024 6:56:09 AM \| Browse: 341 \| Download: 709
23	Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy 6/11/2024 2:35:35 PM \| Browse: 210 \| Download: 888
24	Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome 4/12/2024 1:04:39 AM \| Browse: 199 \| Download: 1558
25	Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK/PGC-1a and inhibiting the RhoA/ROCK pathway 12/14/2023 9:36:12 AM \| Browse: 353 \| Download: 1772
26	Atorvastatin ameliorated myocardial fibrosis in db/db mice by inhibiting oxidative stress and modulating macrophage polarization 12/14/2023 9:36:12 AM \| Browse: 479 \| Download: 1487
27	Potential therapeutic targets for the prevention of diabetic nephropathy: Glycyrrhetinic acid 12/14/2023 9:36:11 AM \| Browse: 412 \| Download: 1202
28	Molecular targets and mechanisms of Jiawei Jiaotai Pill on diabetic cardiomyopathy based on network pharmacology 11/14/2023 6:13:55 AM \| Browse: 481 \| Download: 1701
29	Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy 5/13/2022 10:36:57 AM \| Browse: 782 \| Download: 1919
30	Roles of transient receptor potential channel 6 in glucose-induced cardiomyocyte injury 4/14/2022 11:27:05 AM \| Browse: 781 \| Download: 2356
31	Role of novel biomarkers in diabetic cardiomyopathy 6/4/2021 1:47:10 PM \| Browse: 856 \| Download: 2083
32	Diabetic heart disease: A clinical update 4/9/2021 5:27:04 AM \| Browse: 928 \| Download: 2157
33	Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date 10/15/2019 3:36:45 AM \| Browse: 1121 \| Download: 1774
34	Trace elements in diabetic cardiomyopathy: An electrophysiological overview 9/1/2014 3:13:00 PM \| Browse: 1472 \| Download: 1488
35	Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management 9/1/2014 3:02:00 PM \| Browse: 1312 \| Download: 1350
36	Cardiac autonomic neuropathy in patients with diabetes mellitus 9/1/2014 12:00:00 PM \| Browse: 1831 \| Download: 1820
37	Is diabetic cardiomyopathy a specific entity? 8/27/2014 5:24:00 PM \| Browse: 1126 \| Download: 1256
38	Mechanisms underlying the impaired contractility of diabetic cardiomyopathy 8/22/2014 2:47:00 PM \| Browse: 1264 \| Download: 1418